The purpose of this MAPP is to establish the policy in the Office of Pharmaceutical Quality (OPQ) for a postapproval change in the supplier of a hard gelatin capsule shell. Background The intent of this MAPP is to clarify the reporting category for a change in supplier for a hard gelatin capsule shell. General Policy When an applicant changes the supplier of a hard gelatin capsule shell, with no change in capsule composition or appearance, the information should be submitted in an annual report. If a supplement is received containing a change in the supplier of a hard gelatin capsule shell, OPQ should inform the applicant that the described change is an annual reportable change.

Download to find out more.